Fin Trust Capital Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Fin Trust Capital Advisors, LLC
- $577 Million
- Q3 2024
A detailed history of Fin Trust Capital Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 37 shares of ARWR stock, worth $511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 37
-0.0%
Holding current value
$511
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
95.8MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$217 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$168 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$154 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$83.1 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$72.3 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.46B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...